980nm laser for difficult-to-treat basal cell carcinoma

Aleksandrs Derjabo; Ingrīda Čēma; I. Lihacova; L. Derjabo

980nm laser for difficult-to-treat basal cell carcinoma

Aleksandrs Derjabo, Ingrīda Čēma, I. Lihacova, L. Derjabo

Rīga Stradiņš University

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

60 Downloads (Pure)

Abstract

Begin basal cell carcinoma (BCC) is most common skin cancer over the world. There are around 20 modalities for BCC treatment. Laser surgery is uncommon option. We demonstrate our long term follow up results. Aim: To evaluate long term efficacy of a 980nm diode laser for the difficult-to-treat basal cell carcinoma. Materials and Methods: 167 patients with 173 basal cell carcinoma on the nose were treated with a 980 nm diode laser from May 1999 till May 2005 at Latvian Oncology center. All tumors were morphologically confirmed. 156 patients were followed for more than 5 years. Results: The lowest recurrence rate was observed in cases of superficial BCC, diameter<6mm; bet the highest recurrence rate was in cases of infiltrative BCC and nodular recurrent BCC. Conclusions: 980 nm diode laser is useful tool in dermatology with high long term efficacy, good acceptance by the patients and good cosmetics results.

Original language	English
Title of host publication	European Conference on Biomedical Optics, ECBO 2013
Subtitle of host publication	Medical Laser Applications and Laser-Tissue Interactions VI
Publisher	Optical Society of America
Number of pages	7
Volume	8803
ISBN (Print)	9780819496461
Publication status	Published - 2013
Event	European Conference on Biomedical Optics (ECBO) - Munich, Germany Duration: 12 May 2013 → 16 May 2013

Publication series

Name	Optics InfoBase Conference Papers
ISSN (Electronic)	2162-2701

Conference

Conference	European Conference on Biomedical Optics (ECBO)
Abbreviated title	ECBO 2013
Country/Territory	Germany
City	Munich
Period	12/05/13 → 16/05/13

Keywords*

Basal cell carcinoma
Dermatology
Lasers
Nonmelanoma skin cancer
Oncology
Skin cancer
Treatment

Field of Science*

3.2 Clinical medicine

Publication Type*

3.1. Articles or chapters in proceedings/scientific books indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

980nm laser for difficult-to-treat basal cell carcinomaFinal published version, 473 KB

Cite this

@inproceedings{60db7cae6cfe46b0be2f68c874d353c3,

title = "980nm laser for difficult-to-treat basal cell carcinoma",

abstract = "Begin basal cell carcinoma (BCC) is most common skin cancer over the world. There are around 20 modalities for BCC treatment. Laser surgery is uncommon option. We demonstrate our long term follow up results. Aim: To evaluate long term efficacy of a 980nm diode laser for the difficult-to-treat basal cell carcinoma. Materials and Methods: 167 patients with 173 basal cell carcinoma on the nose were treated with a 980 nm diode laser from May 1999 till May 2005 at Latvian Oncology center. All tumors were morphologically confirmed. 156 patients were followed for more than 5 years. Results: The lowest recurrence rate was observed in cases of superficial BCC, diameter<6mm; bet the highest recurrence rate was in cases of infiltrative BCC and nodular recurrent BCC. Conclusions: 980 nm diode laser is useful tool in dermatology with high long term efficacy, good acceptance by the patients and good cosmetics results.",

keywords = "Basal cell carcinoma, Dermatology, Lasers, Nonmelanoma skin cancer, Oncology, Skin cancer, Treatment",

author = "Aleksandrs Derjabo and Ingrīda {\v C}ēma and I. Lihacova and L. Derjabo",

year = "2013",

language = "English",

isbn = "9780819496461",

volume = "8803",

series = "Optics InfoBase Conference Papers",

publisher = "Optical Society of America",

booktitle = "European Conference on Biomedical Optics, ECBO 2013",

note = "European Conference on Biomedical Optics (ECBO), ECBO 2013 ; Conference date: 12-05-2013 Through 16-05-2013",

}

Derjabo, A, Čēma, I, Lihacova, I & Derjabo, L 2013, 980nm laser for difficult-to-treat basal cell carcinoma. in European Conference on Biomedical Optics, ECBO 2013: Medical Laser Applications and Laser-Tissue Interactions VI. vol. 8803, 88030B, Optics InfoBase Conference Papers, Optical Society of America, European Conference on Biomedical Optics (ECBO), Munich, Germany, 12/05/13.

980nm laser for difficult-to-treat basal cell carcinoma. / Derjabo, Aleksandrs; Čēma, Ingrīda; Lihacova, I. et al.
European Conference on Biomedical Optics, ECBO 2013: Medical Laser Applications and Laser-Tissue Interactions VI. Vol. 8803 Optical Society of America, 2013. 88030B (Optics InfoBase Conference Papers).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review

TY - GEN

T1 - 980nm laser for difficult-to-treat basal cell carcinoma

AU - Derjabo, Aleksandrs

AU - Čēma, Ingrīda

AU - Lihacova, I.

AU - Derjabo, L.

PY - 2013

Y1 - 2013

N2 - Begin basal cell carcinoma (BCC) is most common skin cancer over the world. There are around 20 modalities for BCC treatment. Laser surgery is uncommon option. We demonstrate our long term follow up results. Aim: To evaluate long term efficacy of a 980nm diode laser for the difficult-to-treat basal cell carcinoma. Materials and Methods: 167 patients with 173 basal cell carcinoma on the nose were treated with a 980 nm diode laser from May 1999 till May 2005 at Latvian Oncology center. All tumors were morphologically confirmed. 156 patients were followed for more than 5 years. Results: The lowest recurrence rate was observed in cases of superficial BCC, diameter<6mm; bet the highest recurrence rate was in cases of infiltrative BCC and nodular recurrent BCC. Conclusions: 980 nm diode laser is useful tool in dermatology with high long term efficacy, good acceptance by the patients and good cosmetics results.

AB - Begin basal cell carcinoma (BCC) is most common skin cancer over the world. There are around 20 modalities for BCC treatment. Laser surgery is uncommon option. We demonstrate our long term follow up results. Aim: To evaluate long term efficacy of a 980nm diode laser for the difficult-to-treat basal cell carcinoma. Materials and Methods: 167 patients with 173 basal cell carcinoma on the nose were treated with a 980 nm diode laser from May 1999 till May 2005 at Latvian Oncology center. All tumors were morphologically confirmed. 156 patients were followed for more than 5 years. Results: The lowest recurrence rate was observed in cases of superficial BCC, diameter<6mm; bet the highest recurrence rate was in cases of infiltrative BCC and nodular recurrent BCC. Conclusions: 980 nm diode laser is useful tool in dermatology with high long term efficacy, good acceptance by the patients and good cosmetics results.

KW - Basal cell carcinoma

KW - Dermatology

KW - Lasers

KW - Nonmelanoma skin cancer

KW - Oncology

KW - Skin cancer

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84899725006&partnerID=8YFLogxK

M3 - Conference contribution

AN - SCOPUS:84899725006

SN - 9780819496461

VL - 8803

T3 - Optics InfoBase Conference Papers

BT - European Conference on Biomedical Optics, ECBO 2013

PB - Optical Society of America

T2 - European Conference on Biomedical Optics (ECBO)

Y2 - 12 May 2013 through 16 May 2013

ER -

980nm laser for difficult-to-treat basal cell carcinoma

Abstract

Publication series

Conference

Keywords*

Field of Science*

Publication Type*

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this